SEC Form 4 · accession 0001645627-17-000113
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 29, 2017
Accepted (ET)
Sep 1, 2017 · 2:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 29, 2017 | P | 3,000 | $0.0277 | A | 22,801,189 | D | |
| Common Stock | Aug 29, 2017 | P | 3,000 | $0.025 | A | 22,804,189 | D | |
| Common Stock | Aug 29, 2017 | P | 3,000 | $0.0259 | A | 22,807,189 | D | |
| Common Stock | Aug 29, 2017 | P | 2,000 | $0.026 | A | 22,809,189 | D | |
| Common Stock | Aug 29, 2017 | P | 5,000 | $0.0259 | A | 22,814,189 | D | |
| Common Stock | Aug 29, 2017 | P | 5,000 | $0.0259 | A | 22,819,189 | D | |
| Common Stock | Aug 29, 2017 | P | 3,000 | $0.026 | A | 22,822,189 | D | |
| Common Stock | Aug 30, 2017 | P | 3,000 | $0.0259 | A | 22,825,189 | D | |
| Common Stock | Aug 30, 2017 | P | 3,000 | $0.0258 | A | 22,828,189 | D | |
| Common Stock | Aug 30, 2017 | P | 3,000 | $0.026 | A | 22,831,189 | D | |
| Common Stock | Aug 30, 2017 | P | 3,000 | $0.026 | A | 22,834,189 | D | |
| Common Stock | Aug 30, 2017 | P | 3,000 | $0.0275 | A | 22,837,189 | D | |
| Common Stock | Aug 30, 2017 | P | 3,000 | $0.0275 | A | 22,840,189 | D | |
| Common Stock | Aug 30, 2017 | P | 3,000 | $0.0275 | A | 22,843,189 | D | |
| Common Stock | Aug 31, 2017 | P | 3,000 | $0.0269 | A | 22,846,189 | D | |
| Common Stock | Aug 31, 2017 | P | 3,000 | $0.0261 | A | 22,849,189 | D | |
| Common Stock | Aug 31, 2017 | P | 5,000 | $0.0261 | A | 22,854,189 | D | |
| Common Stock | Aug 31, 2017 | P | 5,000 | $0.0278 | A | 22,859,189 | D | |
| Common Stock | Aug 31, 2017 | P | 5,000 | $0.0277 | A | 22,864,189 | D | |
| Common Stock | Aug 31, 2017 | P | 5,000 | $0.0275 | A | 22,869,189 | D | |
| Common Stock | Aug 31, 2017 | P | 3,000 | $0.0279 | A | 22,872,189 | D | |
| Common Stock | Aug 31, 2017 | P | 5,000 | $0.0265 | A | 22,877,189 | D | |
| Common Stock | Aug 31, 2017 | P | 3,000 | $0.0264 | A | 22,880,189 | D | |
| Common Stock | Aug 31, 2017 | P | 3,000 | $0.0265 | A | 22,883,189 | D |
Table II — derivative securities
No Table II lines on this filing.